NEW YORK (GenomeWeb News) – Agilent Technologies and Roche today announced that Agilent will provide service to NimbleGen microarray customers as Roche shutters that business.

Researchers using NimbleGen microarrays for all applications can transition to Agilent arrays, effective immediately with minimal disruptions, the companies said. Because of the similarities of the two firms' technologies and products, Agilent microarrays can be run on the NimbleGen MS200 Microarray Scanner.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Mar
08
Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.

Apr
03
Sponsored by
Dovetail Genomics

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.